Cookies

Our website uses cookies and other similar tools. We also analyze anonymized web traffic. You can choose your cookie preferences below. You may choose only necessary cookies, specific cookies or all cookies. Read more in our privacy policy

Skip to content
Medaffcon Market Access | Evidence. Access. Impact.

Home > All articles > Patient Dynamics Tool Being Developed for Even Deeper Understanding

Patient Dynamics Tool Being Developed for Even Deeper Understanding

Medaffcon’s Patient Dynamics tool compiles up-to-date and regional data on medicine use in Finland and, more recently, also in Sweden. The tool has been in use for about two years, and Medaffcon continues to develop it to provide pharmaceutical companies with even more precise data.

According to Medaffcon’s Market Access Manager, Timo Karvinen, the tool now makes it possible to access information by medical specialty and by prescriber. Rare disease medicines have also been included, and patient types have been defined. Reports, for example, can show which other medicines are used simultaneously with a particular drug. Cost information can also be incorporated into the analyses.

“The number of therapy areas has expanded, and rare disease medicines and special cases have now been included. That’s where our expertise has been particularly valuable – we have been able to provide solutions for more complex cases,” Karvinen explains.

“Our goal is to obtain data on a health care unit level and to be able to examine treatment lines further than we currently can. We want to reach an even deeper level of information,” he adds.

The data is based on purchases of reimbursed medicines registered with Kela (the Finnish Social Insurance Institution) and is now available both nationwide and regionally. This enables precise allocation of resources to the right areas.

Patient Dynamics Emerged from the Need for More Accurate Data on Medicine Use

Patient Dynamics was created in response to the need for more detailed data on medicine use to support sales and marketing. The tool is particularly valuable for the launch of new medicines or indications but is also used in monitoring established products. It complements sales data by providing insights into, for example, patient numbers and the use of competitors’ products.

Medaffcon works closely with its customers and is transparent about the sources of the data and how the results are derived. Customers also have the option of receiving a comprehensive Excel dashboard for in-depth data analysis. In addition, key analyses can be delivered as a PowerPoint summary.

Back to top